Assembly Biosciences Stock News

SOUTH SAN FRANCISCO, Calif., May 23, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral di Read more

SOUTH SAN FRANCISCO, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative antiviral therapeutics targeti Read more

With the required participation from states and local governments, TEVA can now move forward with the nationwide settlement. Read more

Hot penny stocks to watch with big news this week. The post Penny Stocks To Buy Now? 6 To Watch With Big News Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com Read more

Hot penny stocks to watch with big news this week. The post Penny Stocks To Buy Now? Read more

The heavy selling pressure might have exhausted for Assembly Biosciences (ASMB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Stree Read more

The heavy selling pressure might have exhausted for Assembly Biosciences (ASMB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Stree Read more

Truist Securities cut the price target on Assembly Biosciences, Inc. (NASDAQ: ASMB) from $11 to $2. Assembly Biosciences shares gained 2.6% to trade at $1.58 on Monday. Mizuho cut the price target f Read more

Upgrades Guggenheim upgraded the previous rating for Teladoc Health Inc (NYSE:TDOC) from Sell to Neutral. Teladoc Health earned $0.44 in the second quarter, compared to $0.86 in the year-ago quarter. Read more

Four poster presentations, including two late breaking, highlight breadth and promise of virology portfolio Read more

Dr. McHutchison will continue to provide strategic counsel as board member and chairman of the Science & Technology Committee of the board Dr. McHutchison will continue to provide strategic counsel as Read more

SOUTH SAN FRANCISCO, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative, investigational therapeutics t Read more

Assembly Biosciences (ASMB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Read more

PI, INST and ASMB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 4, 2022. Read more

Assembly Biosciences (ASMB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Read more